日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cardiovascular safety of gabapentinoids gabapentin & pregabalin: A systematic review

加巴喷丁类药物（加巴喷丁和普瑞巴林）的心血管安全性：系统评价

期刊:Indian Journal of Medical Research
影响因子:2.5
doi:10.25259/IJMR_1990_2024
Dutta, Deep; Mohindra, Ritin; Kumar, Manoj; Banerjee, Mainak; Sharma, Meha; Mukhopadhyay, Satinath
发表日期：2025
文献求助 收藏

Safety of Rapid Intermittent Bolus versus Slow Continuous Infusion of Hypertonic Saline for Managing Symptomatic Severe Hyponatremia: A Systematic Review and Meta-analysis

快速间歇推注与缓慢持续输注高渗盐水治疗症状性重度低钠血症的安全性：系统评价和荟萃分析

期刊:Annals of African Medicine
影响因子:0.7
doi:10.4103/aam.aam_249_24
Dutta, Deep; Kumar, Manoj; Joshi, Ameya; Sharma, Meha
发表日期：2025
文献求助 收藏

Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis

胰高血糖素样肽-1受体激动剂疗法治疗阻塞性睡眠呼吸暂停的疗效和安全性：系统评价和荟萃分析

期刊:Indian Journal of Endocrinology and Metabolism
影响因子:
doi:10.4103/ijem.ijem_365_24
Dutta, Deep; Jindal, Radhika; Raizada, Nishant; Nagendra, Lakshmi; Kamrul, Hasan Abm; Sharma, Meha
信号转导
发表日期：2025
文献求助 收藏

Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis

双效胰高血糖素样肽-1和胰高血糖素受体激动剂Twincretin Survodutide作为抗肥胖和抗糖尿病药物的疗效和安全性：系统评价和荟萃分析

期刊:Indian Journal of Endocrinology and Metabolism
影响因子:
doi:10.4103/ijem.ijem_366_24
Dutta, Deep; Kamrul-Hasan, Abul B M; Joshi, Ameya; Dhall, Anil; Nagendra, Lakshmi; Sharma, Meha
肥胖
信号转导
代谢
糖尿病
发表日期：2025
文献求助 收藏

Fenofibrate in Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysis

非诺贝特治疗代谢功能障碍相关脂肪肝：系统评价和荟萃分析

期刊:Indian Journal of Endocrinology and Metabolism
影响因子:
doi:10.4103/ijem.ijem_528_24
Kumar, Manoj; Awasthi, Avivar; Dutta, Deep; Joshi, Ameya; Sharma, Meha
脂肪肝
代谢
发表日期：2025
文献求助 收藏

Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in children and young adults: a systematic review and meta-analysis

钠-葡萄糖协同转运蛋白-2抑制剂在儿童和青少年中的安全性和耐受性：系统评价和荟萃分析

期刊:Annals of Pediatric Endocrinology & Metabolism
影响因子:3.3
doi:10.6065/apem.2346162.081
Nagendra, Lakshmi; Dutta, Deep; Girijashankar, Harish Bukkasagar; Khandelwal, Deepak; Lathia, Tejal; Sharma, Meha
发表日期：2024
文献求助 收藏

Orforglipron, a novel non-peptide oral daily glucagon-like peptide-1 receptor agonist as an anti-obesity medicine: A systematic review and meta-analysis

奥福格列酮，一种新型非肽类口服每日一次的胰高血糖素样肽-1受体激动剂，作为抗肥胖药物：系统评价和荟萃分析

期刊:Obesity Science & Practice
影响因子:1.9
doi:10.1002/osp4.743
Dutta, Deep; Nagendra, Lakshmi; Anne, Beatrice; Kumar, Manoj; Sharma, Meha; Kamrul-Hasan, A B M
肥胖
信号转导
代谢
发表日期：2024
文献求助 收藏

Gender differences in the management and outcomes of acute coronary syndrome in indians: A systematic review and meta-analysis

印度人急性冠脉综合征治疗及预后中的性别差异：系统评价和荟萃分析

期刊:Indian Heart Journal
影响因子:1.8
doi:10.1016/j.ihj.2024.10.002
Dutta, Deep; Mahajan, Kunal; Verma, Lokesh; Gupta, Gunjan; Sharma, Meha
发表日期：2024
文献求助 收藏

Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis

二肽基肽酶-4抑制剂阿那格列汀在2型糖尿病治疗中的作用：系统评价和荟萃分析

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000038870
Kamrul-Hasan, A B M; Dutta, Deep; Nagendra, Lakshmi; Sharma, Meha; Patra, Shinjan; Bhattacharya, Saptarshi
代谢
糖尿病
发表日期：2024
文献求助 收藏

Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis

卡格里林肽单药及联合司美格鲁肽（Cagrisema）作为抗肥胖药物的疗效和安全性：系统评价和荟萃分析

期刊:Indian Journal of Endocrinology and Metabolism
影响因子:
doi:10.4103/ijem.ijem_45_24
Dutta, Deep; Nagendra, Lakshmi; Harish, B G; Sharma, Meha; Joshi, Ameya; Hathur, Basavanagowdappa; Kamrul-Hasan, Abm
肥胖
代谢
发表日期：2024
文献求助 收藏